BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 33158970)

  • 1. Structure of a protective epitope reveals the importance of acetylation of
    Henriques P; Dello Iacono L; Gimeno A; Biolchi A; Romano MR; Arda A; Bernardes GJL; Jimenez-Barbero J; Berti F; Rappuoli R; Adamo R
    Proc Natl Acad Sci U S A; 2020 Nov; 117(47):29795-29802. PubMed ID: 33158970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preclinical immunogenicity study of trivalent meningococcal AWX-OMV vaccines for the African meningitis belt.
    Tunheim G; Naess LM; Acevedo R; Fjeldheim ÅK; Bolstad K; García L; Cardoso D; Aase A; Zayas C; González H; Rosenqvist E; Norheim G
    Vaccine; 2014 Nov; 32(49):6631-8. PubMed ID: 25305564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antigenic determinants driving serogroup-specific antibody response to Neisseria meningitidis C, W, and Y capsular polysaccharides: Insights for rational vaccine design.
    Pietri GP; Bertuzzi S; Karnicar K; Unione L; Lisnic B; Malic S; Miklic K; Novak M; Calloni I; Santini L; Usenik A; Romano MR; Adamo R; Jonjic S; Turk D; Jiménez-Barbero J; Lenac Rovis T
    Carbohydr Polym; 2024 Oct; 341():122349. PubMed ID: 38876728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of O acetylation of Neisseria meningitidis serogroup A capsular polysaccharide on development of functional immune responses.
    Berry DS; Lynn F; Lee CH; Frasch CE; Bash MC
    Infect Immun; 2002 Jul; 70(7):3707-13. PubMed ID: 12065513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective meningococcal capsular polysaccharide epitopes and the role of O acetylation.
    Fusco PC; Farley EK; Huang CH; Moore S; Michon F
    Clin Vaccine Immunol; 2007 May; 14(5):577-84. PubMed ID: 17376859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elucidating the Structural and Minimal Protective Epitope of the Serogroup X Meningococcal Capsular Polysaccharide.
    Pietri GP; Tontini M; Brogioni B; Oldrini D; Robakiewicz S; Henriques P; Calloni I; Abramova V; Santini L; Malić S; Miklić K; Lisnic B; Bertuzzi S; Unione L; Balducci E; de Ruyck J; Romano MR; Jimenez-Barbero J; Bouckaert J; Jonjic S; Rovis TL; Adamo R
    Front Mol Biosci; 2021; 8():745360. PubMed ID: 34722634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigating the immunodominance of carbohydrate antigens in a bivalent unimolecular glycoconjugate vaccine against serogroup A and C meningococcal disease.
    Adamo R; Nilo A; Harfouche C; Brogioni B; Pecetta S; Brogioni G; Balducci E; Pinto V; Filippini S; Mori E; Tontini M; Romano MR; Costantino P; Berti F
    Glycoconj J; 2014 Dec; 31(9):637-47. PubMed ID: 25256065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identifying optimal vaccination strategies for serogroup A Neisseria meningitidis conjugate vaccine in the African meningitis belt.
    Tartof S; Cohn A; Tarbangdo F; Djingarey MH; Messonnier N; Clark TA; Kambou JL; Novak R; Diomandé FV; Medah I; Jackson ML
    PLoS One; 2013; 8(5):e63605. PubMed ID: 23671685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure activity studies on group C meningococcal polysaccharide-protein conjugate vaccines: effect of O-acetylation on the nature of the protective epitope.
    Michon F; Huang CH; Farley EK; Hronowski L; Di J; Fusco PC
    Dev Biol (Basel); 2000; 103():151-60. PubMed ID: 11214233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutant Native Outer Membrane Vesicles Combined with a Serogroup A Polysaccharide Conjugate Vaccine for Prevention of Meningococcal Epidemics in Africa.
    Pajon R; Fergus AM; Granoff DM
    PLoS One; 2013; 8(6):e66536. PubMed ID: 23805230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bordetella pertussis fimbriae are effective carrier proteins in Neisseria meningitidis serogroup C conjugate vaccines.
    Reddin KM; Crowley-Luke A; Clark SO; Vincent PJ; Gorringe AR; Hudson MJ; Robinson A
    FEMS Immunol Med Microbiol; 2001 Aug; 31(2):153-62. PubMed ID: 11549423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and immunogenicity of a booster dose of meningococcal (groups A, C, W, and Y) polysaccharide diphtheria toxoid conjugate vaccine.
    Robertson CA; Greenberg DP; Hedrick J; Pichichero M; Decker MD; Saunders M
    Vaccine; 2016 Oct; 34(44):5273-5278. PubMed ID: 27642132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crystallization and preliminary X-ray diffraction analysis of antigen-binding fragments which are specific for antigenic conformations of sialic acid homopolymers.
    Patenaude SI; Vijay SM; Yang QL; Jennings HJ; Evans SV
    Acta Crystallogr D Biol Crystallogr; 1998 Sep; 54(Pt 5):1005-7. PubMed ID: 9757121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Active immunization against serogroup B Neisseria meningitidis].
    Navarro-Alonso JA
    Enferm Infecc Microbiol Clin; 2003 Nov; 21(9):513-9. PubMed ID: 14572386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Memory immune response generated in Cercopithecus aethiops against meningococcal polysaccharide serogroup C conjugate vaccine.
    Carmenate T; Guirola M; Alvarez A; Canaán L; González S; Caballero E; Menéndez T; Guillén G
    FEMS Immunol Med Microbiol; 2005 Feb; 43(2):133-40. PubMed ID: 15681142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of Escherichia coli K1 colominic acid-specific murine antibodies that are cross-protective against Neisseria meningitidis groups B, C, and Y.
    Park IH; Lin J; Choi JE; Shin JS
    Mol Immunol; 2014 Jun; 59(2):142-53. PubMed ID: 24603121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adolescent meningococcal serogroup A, W and Y immune responses following immunization with quadrivalent meningococcal A, C, W and Y conjugate vaccine: Optimal age for vaccination.
    van Ravenhorst MB; van der Klis FRM; van Rooijen DM; Sanders EAM; Berbers GAM
    Vaccine; 2017 Aug; 35(36):4753-4760. PubMed ID: 28647167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epitopes recognized by a nonautoreactive murine anti-N-propionyl meningococcal group B polysaccharide monoclonal antibody.
    Moe GR; Dave A; Granoff DM
    Infect Immun; 2005 Apr; 73(4):2123-8. PubMed ID: 15784554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Meningococcal quadrivalent (serogroups A, C, W135, and Y) conjugate vaccine (Menveo(®)): profile report.
    Deeks ED
    Paediatr Drugs; 2012 Feb; 14(1):63-5. PubMed ID: 22149552
    [No Abstract]   [Full Text] [Related]  

  • 20. Salivary and Serum Antibody Response Against Neisseria meningitidis After Vaccination With Conjugate Polysaccharide Vaccines in Ethiopian Volunteers.
    Bårnes GK; Workalemahu B; Kristiansen PA; Beyene D; Merdekios B; Fissiha P; Aseffa A; Caugant DA; Naess LM
    Scand J Immunol; 2016 Aug; 84(2):118-29. PubMed ID: 27219622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.